208P Safety and efficacy of immune checkpoint inhibitors in NSCLC patients with autoimmune disease: A UK tertiary cancer centre experience

Autor:	Sawhney, P., Patel, G., Ohana, D., Luong, M.K., Wong, Y.N.S., Lee, A.J.X., Lee, S-M., Forster, M.D.
Zdroj:	In Journal of Thoracic Oncology April 2021 16(4) Supplement:S810-S810
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu